Drug delivery system lab(nanjing university)_drug development and to transfer



1401 Mengming Wei Building, Nanjing University: +86-25-83596143
	HomepageIntroduction People Publication Books ResourcesNanjing EffectPharm Technology support中文

Our Products in the Market or Clinical Trial		Recearch Direction	News More
	1. Fluoxetine Sustained ReleaseTabletes (Marketing) 2. Endostatin PLGA-Microspher for Iinjection (Preclinical Research) 3. Zanamavir Capsules for Inhalation 4. Compound Lovastatin Nicotinic Acid Sustained Release Tabletes (Clinical Trial) 5. Compound Enalapril Maleate and Felodipine Sustained Release Tablets (Clinical Trial)	1. Antineoplastic Conjugates of Transferin and Bioreductant 2. 1416, a New P-glycoprotein Inhibitor Some of our patents in China a) Useful Conjugates of Trasferrin and Tirapazamine for Treatment of Tumors b) A New Compound 1416 with Activity of Inhibiting P-gp	Seminar. Time: May 6, 2008 , 2:00 PM. Room 1708 （2008-5-5） Seminar. Time: Apr 29, 2008 , 2:00 PM. Room 1708 （2008-4-28） Seminar. Time: Apr 15, 2008 , 2:00 PM. Room 1708 （2008-4-14） Seminar. Time: Apr 1, 2008 , 2:00 PM. Room 1708 （2008-4-1） New semster（2008-3-1） Seminar. Time: Jun 22, 2008 , 2:00 PM. Room 1708 （2008-1-11） Happy new year!（2008-1-1） Seminar. Time: Nov 27, 2007 , 2:00 PM. Room 1708 （2007-11-26） Seminar. Time: Nov 6, 2007 , 2:00 PM. Room 1708 （2007-10-28） Photo（2007-10-28） Happy Mid-autumn day!（2007-9-25） Wellcome new people（2007-9-24） New resources（2007-7-4） Group Photo （2007-6-22）


	Album	A New Anticancer Drug Carrier	Lab's Index of Reagent
Certification （ICP No.05077151） Copyright@2006 Nanjing University Drug Delivery System ，Made by ：Wu Jinhui

Untitled Document